Clinical Trials Browser

OTHER × Interventional × Growth Hormone-Secreting Pituitary Adenoma × Clear all

Growth Hormone-Secreting Pituitary Adenoma

NCT03807076 2023-11-29

GA-9

Phase NA Completed

25 enrolled

Endocrine

Growth Hormone-Secreting Pituitary Adenoma

NCT00601289 2020-07-31

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Phase 2 Withdrawn

CNSEndocrine

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

90 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT01775332 2015-07-31

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

Phase NA Unknown

60 enrolled

Endocrine

Gigantism, Pituitary Neoplasms, Prolactinoma, Growth Hormone-Secreting Pituitary Adenoma, ACTH-Secreting Pituitary Adenoma

Clinical Trials

KETOACRO

GA-9

Temozolomide in Treating Patients With Invasive Pituitary Tumors

MERGE

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools